Skip to content
Search

Latest Stories

UK government unveiled £7.5m launchpad to advance growth agenda

The funding boost would help advance healthcare solutions and medical breakthroughs in Northern Ireland

The ‘Life and Health Sciences Launchpad’ has been introduced to focus on the precision medicine sector.


It would help businesses and researchers to level up their impact on economic growth within the region.

The launchpad has been funded by Innovate UK, part of UK Research and Innovation (UKRI).

Kerry Curran, Director of GB & EU Trade in the Department for the Economy hailed the decision to support NI’s “trailblazing” sector.

DfE 01 e1698231436996 (Left to Right) Kerry Curran, Director of GB & EU Trade in the Department for the Economy, Brendan McGurgan, Head of life sciences at Invest NI and Joann Rhodes, CEO of Health Innovation Research Alliance. Credit: Dept. of Economy, NI

She said: ”Life and Health Science, including our highly innovative precision medicine cluster, is an area the Department is also prioritising through its 10X Economy Vision, and this Launchpad represents a further endorsement of the world-leading growth potential of precision medicine, and indeed life and health science, in Northern Ireland.

The Department looks forward to working with partners across the life and health science ecosystem to maximise the benefits and harness the growth potential of this opportunity.”

The launchpad had been designed to build on innovation clusters around the UK that have significant growth potential and to deliver jobs, growth, and higher productivity.

It would also help Small and Medium Enterprises (SMEs) in the life and health science sector to innovate, grow, and scale their businesses.

The competition is due to open on October 30 with grants offered from £15,000 to £1 million for projects that provide exceptional impact to the region.

However, the condition is SMEs must be actively growing their work in the precision medicine sector including diagnostics, med-tech, digital or therapeutics.

They are invited to sign up for a briefing on November 10 in the north-west and an Innovate-UK KTN event on November 23 in Lisburn.

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less